# Max Kholin

> Maxim (Max) Kholin is the co-founder and COO of Gero, a physics-powered longevity biotech company applying statistical physics and AI to crack the biology of aging. With roots in contract law, international business, and computational drug design, he bridges the gap between cutting-edge science and real-world commercialization. Gero - which he co-founded with physicist Peter Fedichev in 2015 - has pioneered the field of 'Gerophysics,' trained its models on 100M+ longitudinal medical records, and secured partnerships with Pfizer and Chugai Pharmaceutical worth up to $250M in milestones. Based across Singapore and Palo Alto, Kholin's mission is nothing less than transforming humans into a non-aging species.

- **Role:** Co-founder & COO at Gero
- **Organizations:** Gero, Quantum Pharmaceuticals, Lifeboat Foundation
- **Nationality:** Russian
- **Education:** Master of Arts, Financial Management and Law, Moscow Financial University
- **Known for:** Co-founded Gero, pioneering the Gerophysics discipline that was later recognized by Nature as a standalone scientific field, Secured partnership with Pfizer for fibrotic disease target identification (2023), Led $6M Series A extension in October 2023 with participation from VitaDAO and EPAM founder Leonid Lozner

## Career timeline

- **2001** — Graduated from Moscow Financial University with MA in Financial Management and Law
- **2001-2010** — Worked as legal advisor in international and domestic businesses; expertise in contract law, IP, corporate law, and investments
- **~2010** — Co-founded Quantum Pharmaceuticals, a computational drug design company; developed structure-based drug design technologies and first-in-class drug candidates
- **2015** — Co-founded Gero with physicist Peter Fedichev to apply physics-based models to aging research
- **2018** — Gero formally incorporated; published 'Hacking Aging' paper in Frontiers in Genetics
- **2021** — Gero's platform trained on 100M+ longitudinal medical records; physics-informed AI models developed
- **2023** — Gero entered research collaboration with Pfizer for fibrotic disease target identification
- **2023-10** — Led $6M Series A extension round led by Melnichek Investments, with VitaDAO and Leonid Lozner (EPAM founder) participating
- **2024** — Nature recognized Gerophysics as standalone scientific field; Gero published in Nature collection
- **2025** — Co-founded role confirmed as COO; Gero presented at ARDD 2025 conference on radical life extension
- **2025-07** — Gero signed joint research and license agreement with Chugai Pharmaceutical; potential milestones up to $250M

## Achievements

- Co-founded Gero, pioneering the Gerophysics discipline that was later recognized by Nature as a standalone scientific field
- Secured partnership with Pfizer for fibrotic disease target identification (2023)
- Led $6M Series A extension in October 2023 with participation from VitaDAO and EPAM founder Leonid Lozner
- Negotiated joint research and license agreement with Chugai Pharmaceutical worth up to $250M in milestones
- Co-authored 'Hacking Aging' paper published in Frontiers in Genetics, outlining Gero's scientific approach
- Built Gero's AI platform on 100M+ longitudinal medical records - one of the world's largest aging datasets
- Prior to Gero, led technology licensing deals with top-20 global pharma companies at Quantum Pharmaceuticals
- Serves on advisory boards of the Lifeboat Foundation

## Latest updates

- **2025-07** — Gero signed joint research and license agreement with Chugai Pharmaceutical for novel antibody therapeutics targeting age-related diseases, with potential milestone payments up to $250M
- **2025-01** — Presented 'Engineering the Path to Radical Life Extension' at ARDD 2025 (12th Aging Research and Drug Discovery meeting)
- **2024-01** — Nature published a dedicated Gerophysics collection co-edited by Peter Fedichev and Brian K. Kennedy, cementing the field Gero helped create
- **2023-10** — Raised $6M Series A extension led by Melnichek Investments, with VitaDAO and Leonid Lozner participating

## Links

- Website: https://gero.ai
- LinkedIn: https://www.linkedin.com/in/maximkholin/
- Twitter/X: https://twitter.com/hacking_aging
- Facebook: https://www.facebook.com/geroscience

---

Profile page: https://yespress.io/max-kholin
Published by YesPress — https://yespress.io
Last updated: 2026-05-25